Kiwa Bio-Tech Products Group Corp (fka KWBT)

[Scherzman]

I did not follow that much after the death of my father, but still have a huge number of shares.

Xiaoman is a well known company in China with excellent reputation. I checked this with various of my Chinese friends.

Questions are:

- how many shares they will issue to “pay” old BOD of KIWA (and of course to benefit themselves)? (they also pay Wei Li for his life work with that; so also his expectations in this deal should be huge; but I think it will be more about the future value of the shares, not the number)

- which assets will Xiaoman give into Kiwa?

- how will Chinese companies perform in the future in US stock market?

But according to my estimation this “new” company should have a market cap of more than one billion US. This whole story turns by chance for all existing shareholders in a new, but promising direction!